Synthetic Biology – Products

Range of sample tubes from Azenta Life Sciences, including external and internal thread tubes, with coding options such as 2D-coded, dual-coded and tri-coded. At the forefront of developing sample storage consumables since 1999.

The teams aim to redefine plasmid sequencing with nanopore technology and global accessibility.

Research shows new process doubles precision fermentation yields and decreases production time.

Beckman Coulter Life Sciences has entered a collaborative partnership with Watchmaker Genomics. The partnership harnesses the value of each organization to deliver robust and reliable automated liquid handling solutions.

Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated.

Invitrogen™ GeneArt™ services provide gene synthesis support from DNA design to protein production.

ExpressPlex™ HT NGS library preparation kit containing 6,144 indices can significantly reduce bottlenecks in plasmid and amplicon sequencing for synthetic biology, gene editing, and protein engineering applications.

The Agilent ProteoAnalyzer system is a parallel capillary electrophoresis instrument that automates the capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) analysis of reduced and non-reduced protein samples. Able to separate 12 samples in as little as 30 minutes, this system is designed to eliminate the laborious process of SDS-PAGE gel preparation, staining/destaining, and analysis so you can focus on results.
The ProteoAnalyzer system separates proteins from 10 to 240 kDa allowing for the analysis of proteins over a wide range of sizes in a single run. The discrete individual capillaries are rejuvenated between every separation allowing for the analysis of diverse samples including monoclonal antibodies, biosimilars, protein purification fractions, and crude cell lysates. The system adds efficiency, versatility, and reliability, particularly in your protein QC workflows.

New off-the-shelf system reduces the cost and risk of lentiviral (LV) production for cell and gene therapy developers. Single-plasmid transfection minimizes GMP plasmid costs and supply chain risk.

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.